Arrowstreet Capital’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-208,768
Closed -$251K 1546
2023
Q1
$251K Hold
208,768
﹤0.01% 1268
2022
Q4
$296K Buy
+208,768
New +$448K ﹤0.01% 1205
2022
Q1
Sell
-70,919
Closed -$642K 1615
2021
Q4
$642K Buy
+70,919
New +$659K ﹤0.01% 1245
2021
Q3
Sell
-23,037
Closed -$296K 1947
2021
Q2
$296K Sell
23,037
-88,200
-79% -$1.21M ﹤0.01% 1743
2021
Q1
$1.57M Sell
111,237
-620,170
-85% -$8.54M ﹤0.01% 1648
2020
Q4
$7.8M Sell
731,407
-171,437
-19% -$1.56M 0.01% 993
2020
Q3
$6.9M Sell
902,844
-132,947
-13% -$978K 0.01% 1000
2020
Q2
$6.28M Buy
1,035,791
+463,992
+81% +$2.29M 0.01% 964
2020
Q1
$2.01M Buy
571,799
+175,499
+44% +$1.49M 0.01% 1060
2019
Q4
$4.18M Buy
+396,300
New +$3.52M 0.01% 914
2019
Q2
Sell
-55,925
Closed -$619K 1793
2019
Q1
$619K Buy
+55,925
New +$391K ﹤0.01% 1436
2014
Q2
Sell
-32,313
Closed -$1.29M 1228
2014
Q1
$1.29M Buy
+32,313
New +$1.16M 0.01% 769

Other funds holding DBD

Arrowstreet Capital's DBD Position: Q2 2023 in Review

Arrowstreet Capital sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 208,768 shares — an estimated $251K sold.

Arrowstreet Capital first reported a position in DBD in Q1 2014 and held it in 12 quarters. The position peaked at $7.8M in Q4 2020. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

  • Arrowstreet Capital reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
  • Arrowstreet Capital sold 208,768 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $251K.
  • Arrowstreet Capital first reported a position in Diebold Nixdorf Incorporated in Q1 2014 and held it in 12 quarters.
  • Arrowstreet Capital's Diebold Nixdorf Incorporated position peaked at $7.8M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Arrowstreet Capital's 13F filing for Q2 2023, filed 14 Aug 2023.